Cell Expansion Market by Product (Reagent, Media, Flow Cytometer, Centrifuge, Bioreactor), Cell Type (Human, Animal), Application (Regenerative Medicine & Stem Cell Research, Cancer & Cell-based Research), End User, and Region - Global Forecast to 2024

細胞増殖の世界市場予測(~2024年)

◆タイトル:Cell Expansion Market by Product (Reagent, Media, Flow Cytometer, Centrifuge, Bioreactor), Cell Type (Human, Animal), Application (Regenerative Medicine & Stem Cell Research, Cancer & Cell-based Research), End User, and Region - Global Forecast to 2024
◆商品コード:BT-2850
◆調査・発行会社:MarketsandMarkets
◆発行日:2019年4月1日
◆ページ数:172
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD5,650 ⇒換算¥621,500見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥731,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥896,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、細胞増殖の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品別(試薬、培地、フローサイトメトリー、遠心分離機、バイオリアクター)分析、細胞種類別(ヒト、動物)分析、用途別(再生医療・幹細胞研究、癌・細胞ベース研究)分析、エンドユーザー別(病院、医薬品、バイオテクノロジー)分析、細胞増殖の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

“Cell expansion market to register a CAGR of 15.4% from 2019 to 2024”
The cell expansion market is projected to reach USD 26.0 Billion by 2024 from USD 12.7 Billion in 2019, at a CAGR of 15.4% during the forecast period. Growth in this market is mainly driven by the increasing incidence of chronic diseases, government investments for cell-based research, the growing focus on personalized medicine, increasing focus on R&D for cell-based therapies, and increasing GMP certifications for cell therapy production facilities.

“Consumables accounted for the larger share of the cell expansion market in 2018”
On the basis of products, the cell expansion market is segmented into consumables and instruments. Consumables are segmented into reagents, media, sera, and disposables. The instruments segment includes cell expansion supporting equipment, bioreactors, and automated cell expansion systems. In 2018, consumables accounted for the largest share of the cell expansion products market owing to the constant requirement for new reagents among end users and rising investments for R&D on cell-based therapies.

“Human cells accounted for the largest share of the cell expansion market in 2018”
Based on cell type, the cell expansion market is segmented into human cells and animal cells. The human cells segment includes stem cells and differentiated cells. The stem cells segment is further classified into adult stem cells, ESCs, and iPSCs. These cells are used for therapeutic and research purposes. In 2018, the human cells segment accounted for the larger share of the cell expansion market majorly due to the increasing investments by public and private organizations for research on human cells, growing application areas of human stem cells, and the growing incidence of diseases such as cancer.

“North America dominates the cell expansion market”
North America, which includes the US and Canada, accounted for the largest share of the cell expansion in 2018. The large share of this market segment can be attributed to the government funding for cancer research, increasing awareness regarding advanced treatment theories, and the strong presence of industry players in the region.

Breakdown of supply-side primary interviews, by company type, designation, and region:
• By Company Type: Tier 1: 70% , Tier 2: 20%, and Tier 3: 10%
• By Designation: C-level: 30%, Director-level: 20%, and Others: 50%
• By Region: North America: 35%, Europe: 24%, Asia: 25%, and the RoW: 16%

The major players operating in this market are Thermo Fisher Scientific, Inc. (US), Becton, Dickinson and Company (US), Terumo BCT (Japan), Merck KGaA (Germany), Danaher Corporation (US), Miltenyi Biotec (Germany), Lonza Group Ltd. (Switzerland), STEMCELL Technologies Inc. (Canada), GE Healthcare (US), and Corning, Inc. (US).

Research Coverage
This report studies the cell expansion market based on product, cell type, application, end user, and region. The report also analyzes factors (such as drivers, restraints, and opportunities) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total cell expansion market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:
The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on the cell expansion offered by the top 10 players in the market. The report analyzes the cell expansion market by product and region

• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various cell expansion across key geographic regions

• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cell expansion market

• Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the cell expansion market

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 18
1.1 OBJECTIVES OF THE STUDY 18
1.2 MARKET DEFINITION 18
1.2.1 MARKETS COVERED 19
1.2.2 COUNTRY COVERAGE 19
1.2.3 YEARS CONSIDERED FOR THE STUDY 20
1.3 CURRENCY 20
1.4 LIMITATIONS 20
1.5 STAKEHOLDERS 20
2 RESEARCH METHODOLOGY 21
2.1 SECONDARY DATA 21
2.1.1 KEY DATA FROM SECONDARY SOURCES 22
2.2 PRIMARY DATA 22
2.2.1 KEY DATA FROM PRIMARY SOURCES 23
2.3 MARKET SIZE ESTIMATION 24
2.3.1 BOTTOM-UP APPROACH 24
2.3.2 TOP-DOWN APPROACH 25
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 25
2.5 ASSUMPTIONS FOR THE STUDY 26
3 EXECUTIVE SUMMARY 27
4 PREMIUM INSIGHTS 31
4.1 CELL EXPANSION MARKET: MARKET OVERVIEW 31
4.2 NORTH AMERICA: CELL EXPANSION MARKET, BY PRODUCT (2018) 32
4.3 GEOGRAPHICAL SNAPSHOT OF THE CELL EXPANSION MARKET 33
5 MARKET OVERVIEW 34
5.1 INTRODUCTION 34
5.2 MARKET DYNAMICS 34
5.2.1 DRIVERS 34
5.2.1.1 Increasing incidence of chronic diseases 34
5.2.1.2 Government investments for cell-based research 35
5.2.1.3 Growing focus on personalized medicine 36
5.2.1.4 Increasing focus on R&D for cell-based therapies 36
5.2.1.5 Increasing GMP certifications for cell therapy production facilities 37
5.2.2 RESTRAINTS 38
5.2.2.1 Ethical concerns regarding research in cell biology 38
5.2.3 OPPORTUNITIES 38
5.2.3.1 Emerging markets 38
5.2.3.2 3D cell expansion technology 38
6 CELL EXPANSION MARKET, BY PRODUCT 39
6.1 INTRODUCTION 40
6.2 CONSUMABLES 41
6.2.1 MEDIA 42
6.2.1.1 Media segment to dominate the cell expansion consumables market 42
6.2.2 REAGENTS 42
6.2.2.1 Reagents segment to account for the second-largest share of the cell expansion consumables market 42
6.2.3 SERA 43
6.2.3.1 North America to dominate the cell expansion sera market 43
6.2.4 DISPOSABLES 44
6.2.4.1 Tissue culture flasks 45
6.2.4.1.1 Tissue culture flasks segment accounted for the largest share of the disposables market 45
6.2.4.2 Bioreactor accessories 45
6.2.4.2.1 Bioreactor accessories segment accounted for the second-largest share of the disposables market 45
6.2.4.3 Other disposables 46
6.3 INSTRUMENTS 47
6.3.1 CELL EXPANSION SUPPORTING EQUIPMENT 48
6.3.1.1 Flow cytometers 48
6.3.1.1.1 Product launches to drive the growth of this
market segment 48
6.3.1.2 Centrifuges 49
6.3.1.2.1 Major players are focusing on launching new and advanced centrifuges in the market 49
6.3.1.3 Cell counters & Hemocytometers 50
6.3.1.3.1 Technological advancements supporting the growth of the cell counters & hemocytometers market 50
6.3.1.4 Other supporting equipment 50
6.3.2 BIOREACTORS 51
6.3.2.1 Microcarrier bioreactors 51
6.3.2.1.1 Microcarrier-based anchorage-dependent bioreactors 52
6.3.2.1.1.1 Microcarrier-based anchorage-dependent bioreactors offer large-scale production 52
6.3.2.1.2 Suspension-based anchorage-independent bioreactors 53
6.3.2.1.2.1 North America is the largest market for suspension-based anchorage-independent bioreactors 53
6.3.2.2 Perfusion/hollow fiber bioreactors 53
6.3.2.2.1 Collaborations and product launches supporting the growth of this market segment 53
6.3.3 AUTOMATED CELL EXPANSION SYSTEMS 54
6.3.3.1 Technological advancements to drive the growth of this
market segment 54
7 CELL EXPANSION MARKET, BY CELL TYPE 56
7.1 INTRODUCTION 57
7.2 HUMAN CELLS 58
7.2.1 STEM CELLS 58
7.2.1.1 Adult stem cells 59
7.2.1.1.1 Adult stem cells segment accounts for the largest share of the human stem cells market, primarily due to increased government initiatives in cell-based research 59
7.2.1.2 Induced pluripotent stem cells (iPSCs) 60
7.2.1.2.1 iPSCs are sued in cell replacement therapies, drug screening, and tissue regeneration 60
7.2.1.3 Embryonic stem cells (ESCs) 61
7.2.1.3.1 Increasing private and public investments for stem cell research—major factor driving market growth 61
7.2.2 DIFFERENTIATED CELLS 62
7.2.2.1 Increasing prevalence of cancer is the major factor driving the growth of this market 62
7.3 ANIMAL CELLS 63
7.3.1 BIOPHARMACEUTICAL COMPANIES ARE THE MAJOR END USERS OF
ANIMAL CELLS 63
8 CELL EXPANSION MARKET, BY APPLICATION 64
8.1 INTRODUCTION 65
8.2 REGENERATIVE MEDICINE AND STEM CELL RESEARCH 66
8.2.1 INCREASING GOVERNMENT FUNDING ON REGENERATIVE MEDICINE AND STEM CELL RESEARCH TO DRIVE MARKET GROWTH 66
8.3 CANCER AND CELL-BASED RESEARCH 67
8.3.1 INCREASING PREVALENCE OF CANCER TO SUPPORT MARKET GROWTH 67
8.4 OTHER APPLICATIONS 67
9 CELL EXPANSION MARKET, BY END USER 69
9.1 INTRODUCTION 70
9.2 BIOTECHNOLOGY & BIOPHARMACEUTICAL COMPANIES 71
9.2.1 INCREASING INVESTMENTS IN CELL-BASED RESEARCH TO DRIVE
MARKET GROWTH 71
9.3 RESEARCH INSTITUTES 71
9.3.1 GROWTH IN FUNDING FOR LIFE SCIENCE RESEARCH TO DRIVE THE MARKET FOR RESEARCH INSTITUTES 71
9.4 CELL BANKS 72
9.4.1 INCREASING AWARENESS AMONG PEOPLE ABOUT THE BENEFITS OF PRESERVING STEM CELLS TO DRIVE MARKET GROWTH 72
9.5 OTHER END USERS 73
10 CELL EXPANSION MARKET, BY REGION 74
10.1 INTRODUCTION 75
10.2 NORTH AMERICA 76
10.2.1 US 80
10.2.1.1 US to witness the highest growth in the North American cell expansion market due to the increasing government funding on cell-based research 80
10.2.2 CANADA 83
10.2.2.1 Increasing funding for research in regenerative medicine to support market growth in Canada 83
10.3 EUROPE 86
10.3.1 GERMANY 89
10.3.1.1 Germany is the fastest-growing market for cell expansion in Europe 89
10.3.2 FRANCE 91
10.3.2.1 Robust biotechnology infrastructure in the country to support
market growth 91
10.3.3 UK 94
10.3.3.1 Government investments in stem cell research to drive the market for cell expansion in the UK 94
10.3.4 ITALY 97
10.3.4.1 Increasing number of cell biology seminars and conferences to fuel the adoption of cell expansion products 97
10.3.5 SPAIN 100
10.3.5.1 Increasing funding from private and public organizations to aid market growth 100
10.3.6 REST OF EUROPE (ROE) 103
10.4 ASIA PACIFIC 106
10.4.1 JAPAN 109
10.4.1.1 Growing geriatric population in the country to drive market growth 109
10.4.2 CHINA 111
10.4.2.1 Government initiatives to promote stem cell research to play a major role in driving market growth 111
10.4.3 INDIA 114
10.4.3.1 Growing pharmaceutical and biotechnology industries—key growth driver for the cell expansion market in India 114
10.4.4 SINGAPORE 117
10.4.4.1 Presence of leading pharmaceutical companies is supporting the growth of the cell expansion market in the country 117
10.4.5 SOUTH KOREA 120
10.4.5.1 Conferences and research activities on stem cells are supporting the growth of the cell expansion market in the country 120
10.4.6 REST OF ASIA PACIFIC 123

10.5 ROW 126
10.5.1 LATIN AMERICA 129
10.5.1.1 Increasing incidence of cancer to drive the market for cell expansion 129
10.5.2 MIDDLE EAST & AFRICA 132
11 COMPETITIVE LANDSCAPE 135
11.1 OVERVIEW 135
11.2 MARKET SHARE ANALYSIS, 2018 135
11.3 COMPETITIVE SCENARIO 136
11.3.1 PRODUCT LAUNCHES AND APPROVALS, 2016–2019 137
11.3.2 ACQUISITIONS, 2016–2019 137
11.3.3 AGREEMENTS, 2016–2019 137
11.3.4 EXPANSIONS, 2016–2019 138
11.4 COMPETITIVE LEADERSHIP MAPPING (2018) 138
11.4.1 VENDOR INCLUSION CRITERIA 138
11.4.2 VISIONARY LEADERS 138
11.4.3 INNOVATORS 139
11.4.4 DYNAMIC DIFFERENTIATORS 139
11.4.5 EMERGING COMPANIES 139
12 COMPANY PROFILES 141
(Business Overview, Exchange Rates, Products Offered, Recent Developments, and MnM View)*
12.1 THERMO FISHER SCIENTIFIC, INC. 141
12.2 BECTON, DICKINSON AND COMPANY 144
12.3 TERUMO BCT 146
12.4 MERCK KGAA 148
12.5 BECKMAN COULTER INC. (SUBSIDIARY OF DANAHER CORPORATION) 151
12.6 MILTENYI BIOTEC 153
12.7 LONZA GROUP LTD. 155
12.8 STEMCELL TECHNOLOGIES, INC. 157
12.9 GE HEALTHCARE 159
12.10 CORNING INCORPORATED 161
* Business Overview, Exchange Rates, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.

13 APPENDIX 163
13.1 INSIGHTS OF INDUSTRY EXPERTS 163
13.2 DISCUSSION GUIDE 164
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 168
13.4 AVAILABLE CUSTOMIZATIONS 170
13.5 RELATED REPORTS 170
13.6 AUTHOR DETAILS 171

LIST OF TABLES

TABLE 1 GLOBAL PREVALENCE OF DIABETES, BY REGION (MILLION), 2000 VS. 2030 35
TABLE 2 RISING INCIDENCE OF CANCER, BY TYPE (MILLION) 35
TABLE 3 GROWTH IN THE NUMBER OF PERSONALIZED MEDICATIONS, 2008–2016 36
TABLE 4 R&D EXPENDITURE BY PHARMACEUTICAL COMPANIES, 2016 VS. 2017 37
TABLE 5 RISING REGULATORY APPROVALS FOR GMP TO BOOST THE MARKET 37
TABLE 6 CELL EXPANSION MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 40
TABLE 7 CELL EXPANSION CONSUMABLES MARKET, BY REGION,
2017–2024 (USD MILLION) 41
TABLE 8 CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2017–2024 (USD MILLION) 41
TABLE 9 CELL EXPANSION CONSUMABLES MARKET FOR MEDIA, BY REGION,
2017–2024 (USD MILLION) 42
TABLE 10 CELL EXPANSION CONSUMABLES MARKET FOR REAGENTS, BY REGION,
2017–2024 (USD MILLION) 43
TABLE 11 CELL EXPANSION CONSUMABLES MARKET FOR SERA, BY REGION,
2017–2024 (USD MILLION) 43
TABLE 12 CELL EXPANSION DISPOSABLES MARKET, BY REGION, 2017–2024 (USD MILLION) 44
TABLE 13 CELL EXPANSION DISPOSABLES MARKET, BY TYPE, 2017–2024 (USD MILLION) 44
TABLE 14 TISSUE CULTURE FLASKS MARKET, BY REGION, 2017–2024 (USD MILLION) 45
TABLE 15 BIOREACTOR ACCESSORIES MARKET, BY REGION, 2017–2024 (USD MILLION) 46
TABLE 16 OTHER DISPOSABLES MARKET, BY REGION, 2017–2024 (USD MILLION) 46
TABLE 17 CELL EXPANSION INSTRUMENTS MARKET, BY REGION,
2017–2024 (USD MILLION) 47
TABLE 18 CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION) 47
TABLE 19 CELL EXPANSION SUPPORTING EQUIPMENT MARKET, BY TYPE,
2017–2024 (USD MILLION) 48
TABLE 20 FLOW CYTOMETERS MARKET, BY REGION, 2017–2024 (USD MILLION) 49
TABLE 21 CENTRIFUGES MARKET, BY REGION, 2017–2024 (USD MILLION) 49
TABLE 22 CELL COUNTERS & HEMOCYTOMETERS MARKET, BY REGION,
2017–2024 (USD MILLION) 50
TABLE 23 OTHER SUPPORTING EQUIPMENT MARKET, BY REGION,
2017–2024 (USD MILLION) 50
TABLE 24 CELL EXPANSION BIOREACTORS MARKET, BY TYPE, 2017–2024 (USD MILLION) 51
TABLE 25 MICROCARRIER BIOREACTORS MARKET, BY REGION, 2017–2024 (USD MILLION) 51
TABLE 26 MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2017–2024 (USD MILLION) 52
TABLE 27 MICROCARRIER-BASED ANCHORAGE-DEPENDENT BIOREACTORS MARKET,
BY REGION, 2017–2024 (USD MILLION) 52
TABLE 28 SUSPENSION-BASED ANCHORAGE-INDEPENDENT BIOREACTORS MARKET,
BY REGION, 2017–2024 (USD MILLION) 53
TABLE 29 PERFUSION/HOLLOW FIBER BIOREACTORS MARKET, BY REGION,
2017–2024 (USD MILLION) 54
TABLE 30 AUTOMATED CELL EXPANSION SYSTEMS MARKET, BY REGION,
2017–2024 (USD MILLION) 55
TABLE 31 CELL EXPANSION MARKET, BY CELL TYPE, 2017–2024 (USD MILLION) 57
TABLE 32 HUMAN CELLS MARKET, BY TYPE, 2017–2024 (USD MILLION) 58
TABLE 33 STEM CELLS MARKET, BY TYPE, 2017–2024 (USD MILLION) 59
TABLE 34 ADULT STEM CELLS MARKET, BY REGION, 2017–2024 (USD MILLION) 60
TABLE 35 INDUCED PLURIPOTENT STEM CELLS MARKET, BY REGION,
2017–2024 (USD MILLION) 60
TABLE 36 ESCS MARKET, BY REGION, 2017–2024 (USD MILLION) 61
TABLE 37 DIFFERENTIATED CELLS MARKET, BY REGION, 2017–2024 (USD MILLION) 62
TABLE 38 ANIMAL CELLS MARKET, BY REGION, 2017–2024 (USD MILLION) 63
TABLE 39 CELL EXPANSION MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 65
TABLE 40 CELL EXPANSION MARKET FOR REGENERATIVE MEDICINE AND STEM CELL RESEARCH, BY REGION, 2017–2024 (USD MILLION) 66
TABLE 41 CELL EXPANSION MARKET FOR CANCER AND CELL-BASED RESEARCH, BY REGION, 2017–2024 (USD MILLION) 67
TABLE 42 CELL EXPANSION MARKET FOR OTHER APPLICATIONS, BY REGION,
2017–2024 (USD MILLION) 68
TABLE 43 CELL EXPANSION MARKET, BY END USER, 2017–2024 (USD MILLION) 70
TABLE 44 CELL EXPANSION MARKET FOR BIOTECHNOLOGY & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2017–2024 (USD MILLION) 71
TABLE 45 CELL EXPANSION MARKET FOR RESEARCH INSTITUTES, BY REGION,
2017–2024 (USD MILLION) 72
TABLE 46 CELL EXPANSION MARKET FOR CELL BANKS, BY REGION,
2017–2024 (USD MILLION) 72
TABLE 47 CELL EXPANSION MARKET FOR OTHER END USERS, BY REGION,
2017–2024 (USD MILLION) 73
TABLE 48 CELL EXPANSION MARKET, BY REGION, 2017–2024 (USD MILLION) 75
TABLE 49 NORTH AMERICA: CELL EXPANSION MARKET, BY COUNTRY,
2017–2024 (USD MILLION) 77
TABLE 50 NORTH AMERICA: CELL EXPANSION MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 78
TABLE 51 NORTH AMERICA: CELL EXPANSION CONSUMABLES MARKET, BY TYPE,
2017–2024 (USD MILLION) 78
TABLE 52 NORTH AMERICA: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 78
TABLE 53 NORTH AMERICA: CELL EXPANSION MARKET, BY CELL TYPE,
2017–2024 (USD MILLION) 79
TABLE 54 NORTH AMERICA: HUMAN CELLS MARKET, BY TYPE, 2017–2024 (USD MILLION) 79
TABLE 55 NORTH AMERICA: CELL EXPANSION MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 79
TABLE 56 NORTH AMERICA: CELL EXPANSION MARKET, BY END USER,
2017–2024 (USD MILLION) 80
TABLE 57 US: CELL EXPANSION MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 81
TABLE 58 US: CELL EXPANSION CONSUMABLES MARKET, BY TYPE,
2017–2024 (USD MILLION) 81
TABLE 59 US: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 81
TABLE 60 US: CELL EXPANSION MARKET, BY CELL TYPE, 2017–2024 (USD MILLION) 82
TABLE 61 US: HUMAN CELLS MARKET, BY TYPE, 2017–2024 (USD MILLION) 82
TABLE 62 US: CELL EXPANSION MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 82
TABLE 63 US: CELL EXPANSION MARKET, BY END USER, 2017–2024 (USD MILLION) 83
TABLE 64 CANADA: CELL EXPANSION MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 83
TABLE 65 CANADA: CELL EXPANSION CONSUMABLES MARKET, BY TYPE,
2017–2024 (USD MILLION) 84
TABLE 66 CANADA: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 84
TABLE 67 CANADA: CELL EXPANSION MARKET, BY CELL TYPE, 2017–2024 (USD MILLION) 84
TABLE 68 CANADA: HUMAN CELLS MARKET, BY TYPE, 2017–2024 (USD MILLION) 85
TABLE 69 CANADA: CELL EXPANSION MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 85
TABLE 70 CANADA: CELL EXPANSION MARKET, BY END USER, 2017–2024 (USD MILLION) 85
TABLE 71 EUROPE: CELL EXPANSION MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 86
TABLE 72 EUROPE: CELL EXPANSION MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 86
TABLE 73 EUROPE: CELL EXPANSION CONSUMABLES MARKET, BY TYPE,
2017–2024 (USD MILLION) 87
TABLE 74 EUROPE: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 87
TABLE 75 EUROPE: CELL EXPANSION MARKET, BY CELL TYPE, 2017–2024 (USD MILLION) 87
TABLE 76 EUROPE: HUMAN CELLS MARKET, BY TYPE, 2017–2024 (USD MILLION) 88
TABLE 77 EUROPE: CELL EXPANSION MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 88
TABLE 78 EUROPE: CELL EXPANSION MARKET, BY END USER, 2017–2024 (USD MILLION) 88
TABLE 79 GERMANY: CELL EXPANSION MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 89
TABLE 80 GERMANY: CELL EXPANSION CONSUMABLES MARKET, BY TYPE,
2017–2024 (USD MILLION) 89
TABLE 81 GERMANY: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 90
TABLE 82 GERMANY: CELL EXPANSION MARKET, BY CELL TYPE, 2017–2024 (USD MILLION) 90
TABLE 83 GERMANY: HUMAN CELLS MARKET, BY TYPE, 2017–2024 (USD MILLION) 90
TABLE 84 GERMANY: CELL EXPANSION MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 91
TABLE 85 GERMANY: CELL EXPANSION MARKET, BY END USER, 2017–2024 (USD MILLION) 91
TABLE 86 FRANCE: CELL EXPANSION MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 92
TABLE 87 FRANCE: CELL EXPANSION CONSUMABLES MARKET, BY TYPE,
2017–2024 (USD MILLION) 92
TABLE 88 FRANCE: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 93
TABLE 89 FRANCE: CELL EXPANSION MARKET, BY CELL TYPE, 2017–2024 (USD MILLION) 93
TABLE 90 FRANCE: HUMAN CELLS MARKET, BY TYPE, 2017–2024 (USD MILLION) 93
TABLE 91 FRANCE: CELL EXPANSION MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 94
TABLE 92 FRANCE: CELL EXPANSION MARKET, BY END USER, 2017–2024 (USD MILLION) 94
TABLE 93 UK: CELL EXPANSION MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 95
TABLE 94 UK: CELL EXPANSION CONSUMABLES MARKET, BY TYPE,
2017–2024 (USD MILLION) 95
TABLE 95 UK: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 95
TABLE 96 UK: CELL EXPANSION MARKET, BY CELL TYPE, 2017–2024 (USD MILLION) 96
TABLE 97 UK: HUMAN CELLS MARKET, BY TYPE, 2017–2024 (USD MILLION) 96
TABLE 98 UK: CELL EXPANSION MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 96
TABLE 99 UK: CELL EXPANSION MARKET, BY END USER, 2017–2024 (USD MILLION) 97
TABLE 100 ITALY: CELL EXPANSION MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 97
TABLE 101 ITALY: CELL EXPANSION CONSUMABLES MARKET, BY TYPE,
2017–2024 (USD MILLION) 98
TABLE 102 ITALY: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 98
TABLE 103 ITALY: CELL EXPANSION MARKET, BY CELL TYPE, 2017–2024 (USD MILLION) 98
TABLE 104 ITALY: HUMAN CELLS MARKET, BY TYPE, 2017–2024 (USD MILLION) 99
TABLE 105 ITALY: CELL EXPANSION MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 99
TABLE 106 ITALY: CELL EXPANSION MARKET, BY END USER, 2017–2024 (USD MILLION) 99
TABLE 107 SPAIN: CELL EXPANSION MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 100
TABLE 108 SPAIN: CELL EXPANSION CONSUMABLES MARKET, BY TYPE,
2017–2024 (USD MILLION) 100
TABLE 109 SPAIN: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 101
TABLE 110 SPAIN: CELL EXPANSION MARKET, BY CELL TYPE, 2017–2024 (USD MILLION) 101
TABLE 111 SPAIN: HUMAN CELLS MARKET, BY TYPE, 2017–2024 (USD MILLION) 101
TABLE 112 SPAIN: CELL EXPANSION MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 102
TABLE 113 SPAIN: CELL EXPANSION MARKET, BY END USER, 2017–2024 (USD MILLION) 102
TABLE 114 ROE: CELL EXPANSION MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 103
TABLE 115 ROE: CELL EXPANSION CONSUMABLES MARKET, BY TYPE,
2017–2024 (USD MILLION) 103
TABLE 116 ROE: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 104
TABLE 117 ROE: CELL EXPANSION MARKET, BY CELL TYPE, 2017–2024 (USD MILLION) 104
TABLE 118 ROE: HUMAN CELLS MARKET, BY TYPE, 2017–2024 (USD MILLION) 104
TABLE 119 ROE: CELL EXPANSION MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 105
TABLE 120 ROE: CELL EXPANSION MARKET, BY END USER, 2017–2024 (USD MILLION) 105
TABLE 121 ASIA PACIFIC: CELL EXPANSION MARKET, BY COUNTRY,
2017–2024 (USD MILLION) 106
TABLE 122 ASIA PACIFIC: CELL EXPANSION MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 106
TABLE 123 ASIA PACIFIC: CELL EXPANSION CONSUMABLES MARKET, BY TYPE,
2017–2024 (USD MILLION) 107
TABLE 124 ASIA PACIFIC: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 107
TABLE 125 ASIA PACIFIC: CELL EXPANSION MARKET, BY CELL TYPE,
2017–2024 (USD MILLION) 107
TABLE 126 ASIA PACIFIC: HUMAN CELLS MARKET, BY TYPE, 2017–2024 (USD MILLION) 108
TABLE 127 ASIA PACIFIC: CELL EXPANSION MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 108
TABLE 128 ASIA PACIFIC: CELL EXPANSION MARKET, BY END USER,
2017–2024 (USD MILLION) 108
TABLE 129 JAPAN: CELL EXPANSION MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 109
TABLE 130 JAPAN: CELL EXPANSION CONSUMABLES MARKET, BY TYPE,
2017–2024 (USD MILLION) 109
TABLE 131 JAPAN: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 110
TABLE 132 JAPAN: CELL EXPANSION MARKET, BY CELL TYPE, 2017–2024 (USD MILLION) 110
TABLE 133 JAPAN: HUMAN CELLS MARKET, BY TYPE, 2017–2024 (USD MILLION) 110
TABLE 134 JAPAN: CELL EXPANSION MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 111
TABLE 135 JAPAN: CELL EXPANSION MARKET, BY END USER, 2017–2024 (USD MILLION) 111
TABLE 136 CHINA: CELL EXPANSION MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 112
TABLE 137 CHINA: CELL EXPANSION CONSUMABLES MARKET, BY TYPE,
2017–2024 (USD MILLION) 112
TABLE 138 CHINA: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 112
TABLE 139 CHINA: CELL EXPANSION MARKET, BY CELL TYPE, 2017–2024 (USD MILLION) 113
TABLE 140 CHINA: HUMAN CELLS MARKET, BY TYPE, 2017–2024 (USD MILLION) 113
TABLE 141 CHINA: CELL EXPANSION MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 113
TABLE 142 CHINA: CELL EXPANSION MARKET, BY END USER, 2017–2024 (USD MILLION) 114
TABLE 143 INDIA: CELL EXPANSION MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 115
TABLE 144 INDIA: CELL EXPANSION CONSUMABLES MARKET, BY TYPE,
2017–2024 (USD MILLION) 115
TABLE 145 INDIA: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 115
TABLE 146 INDIA: CELL EXPANSION MARKET, BY CELL TYPE, 2017–2024 (USD MILLION) 116
TABLE 147 INDIA: HUMAN CELLS MARKET, BY TYPE, 2017–2024 (USD MILLION) 116
TABLE 148 INDIA: CELL EXPANSION MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 116
TABLE 149 INDIA: CELL EXPANSION MARKET, BY END USER, 2017–2024 (USD MILLION) 117
TABLE 150 SINGAPORE: CELL EXPANSION MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 117
TABLE 151 SINGAPORE: CELL EXPANSION CONSUMABLES MARKET, BY TYPE,
2017–2024 (USD MILLION) 118
TABLE 152 SINGAPORE: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 118
TABLE 153 SINGAPORE: CELL EXPANSION MARKET, BY CELL TYPE,
2017–2024 (USD MILLION) 118
TABLE 154 SINGAPORE: HUMAN CELLS MARKET, BY TYPE, 2017–2024 (USD MILLION) 119
TABLE 155 SINGAPORE: CELL EXPANSION MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 119
TABLE 156 SINGAPORE: CELL EXPANSION MARKET, BY END USER,
2017–2024 (USD MILLION) 119
TABLE 157 SOUTH KOREA: CELL EXPANSION MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 120
TABLE 158 SOUTH KOREA: CELL EXPANSION CONSUMABLES MARKET, BY TYPE,
2017–2024 (USD MILLION) 121
TABLE 159 SOUTH KOREA: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 121
TABLE 160 SOUTH KOREA: CELL EXPANSION MARKET, BY CELL TYPE,
2017–2024 (USD MILLION) 121
TABLE 161 SOUTH KOREA: HUMAN CELLS MARKET, BY TYPE, 2017–2024 (USD MILLION) 122
TABLE 162 SOUTH KOREA: CELL EXPANSION MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 122
TABLE 163 SOUTH KOREA: CELL EXPANSION MARKET, BY END USER,
2017–2024 (USD MILLION) 122
TABLE 164 ROAPAC: CELL EXPANSION MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 123
TABLE 165 ROAPAC: CELL EXPANSION CONSUMABLES MARKET, BY TYPE,
2017–2024 (USD MILLION) 123
TABLE 166 ROAPAC: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 124
TABLE 167 ROAPAC: CELL EXPANSION MARKET, BY CELL TYPE, 2017–2024 (USD MILLION) 124
TABLE 168 ROAPAC: HUMAN CELLS MARKET, BY TYPE, 2017–2024 (USD MILLION) 124
TABLE 169 ROAPAC: CELL EXPANSION MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 125
TABLE 170 ROAPAC: CELL EXPANSION MARKET, BY END USER, 2017–2024 (USD MILLION) 125
TABLE 171 ROW: CELL EXPANSION MARKET, BY REGION, 2017–2024 (USD MILLION) 126
TABLE 172 ROW: CELL EXPANSION MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 126
TABLE 173 ROW: CELL EXPANSION CONSUMABLES MARKET, BY TYPE,
2017–2024 (USD MILLION) 127
TABLE 174 ROW: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 127
TABLE 175 ROW: CELL EXPANSION MARKET, BY CELL TYPE, 2017–2024 (USD MILLION) 127
TABLE 176 ROW: HUMAN CELLS MARKET, BY TYPE, 2017–2024 (USD MILLION) 128
TABLE 177 ROW: CELL EXPANSION MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 128
TABLE 178 ROW: CELL EXPANSION MARKET, BY END USER, 2017–2024 (USD MILLION) 128
TABLE 179 LATIN AMERICA: CELL EXPANSION MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 129
TABLE 180 LATIN AMERICA: CELL EXPANSION CONSUMABLES MARKET, BY TYPE,
2017–2024 (USD MILLION) 130
TABLE 181 LATIN AMERICA: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 130
TABLE 182 LATIN AMERICA: CELL EXPANSION MARKET, BY CELL TYPE,
2017–2024 (USD MILLION) 130
TABLE 183 LATIN AMERICA: HUMAN CELLS MARKET, BY TYPE, 2017–2024 (USD MILLION) 131
TABLE 184 LATIN AMERICA: CELL EXPANSION MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 131
TABLE 185 LATIN AMERICA: CELL EXPANSION MARKET, BY END USER,
2017–2024 (USD MILLION) 131
TABLE 186 MIDDLE EAST & AFRICA: CELL EXPANSION MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 132
TABLE 187 MIDDLE EAST & AFRICA: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2017–2024 (USD MILLION) 132
TABLE 188 MIDDLE EAST & AFRICA: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION) 133
TABLE 189 MIDDLE EAST & AFRICA: CELL EXPANSION MARKET, BY CELL TYPE,
2017–2024 (USD MILLION) 133
TABLE 190 MIDDLE EAST & AFRICA: HUMAN CELLS MARKET, BY TYPE,
2017–2024 (USD MILLION) 133
TABLE 191 MIDDLE EAST & AFRICA: CELL EXPANSION MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 134
TABLE 192 MIDDLE EAST & AFRICA: CELL EXPANSION MARKET, BY END USER,
2017–2024 (USD MILLION) 134


LIST OF FIGURES

FIGURE 1 CELL EXPANSION MARKET 19
FIGURE 2 CELL EXPANSION MARKET, BY REGION 19
FIGURE 3 CELL EXPANSION MARKET YEARS CONSIDERED FOR THE STUDY 20
FIGURE 4 RESEARCH DESIGN 21
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 23
FIGURE 6 CELL EXPANSION MARKET: BOTTOM-UP APPROACH 24
FIGURE 7 CELL EXPANSION MARKET: TOP-DOWN APPROACH 25
FIGURE 8 DATA TRIANGULATION METHODOLOGY 26
FIGURE 9 CELL EXPANSION MARKET, BY PRODUCT, 2019 VS. 2024 (USD MILLION) 27
FIGURE 10 CELL EXPANSION MARKET, BY CELL TYPE, 2019 VS. 2024 (USD MILLION) 28
FIGURE 11 CELL EXPANSION MARKET, BY APPLICATION, 2019 VS. 2024 (USD MILLION) 28
FIGURE 12 CELL EXPANSION MARKET, BY END USER, 2019 VS. 2024 (USD MILLION) 29
FIGURE 13 CELL EXPANSION MARKET, BY REGION, 2019 VS. 2024 (USD MILLION) 29
FIGURE 14 INCREASING INCIDENCE OF CHRONIC DISEASES AND GOVERNMENT INVESTMENTS FOR CELL-BASED RESEARCH TO DRIVE MARKET GROWTH
DURING THE FORECAST PERIOD 31
FIGURE 15 CELL EXPANSION CONSUMABLES TO DOMINATE THE MARKET IN
NORTH AMERICA IN 2018 32
FIGURE 16 COUNTRIES IN ASIA PACIFIC TO REGISTER A HIGHER GROWTH RATE DURING
THE FORECAST PERIOD 33
FIGURE 17 CELL EXPANSION MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES 34
FIGURE 18 CONSUMABLES SEGMENT TO DOMINATE THE CELL EXPANSION PRODUCTS MARKET DURING THE FORECAST PERIOD 40
FIGURE 19 HUMAN CELLS SEGMENT TO DOMINATE THE CELL EXPANSION MARKET DURING THE FORECAST PERIOD 57
FIGURE 20 REGENERATIVE MEDICINE AND STEM CELL RESEARCH SEGMENT TO DOMINATE THE CELL EXPANSION MARKET DURING THE FORECAST PERIOD 65
FIGURE 21 BIOTECHNOLOGY & BIOPHARMACEUTICAL COMPANIES SEGMENT TO DOMINATE THE CELL EXPANSION MARKET DURING THE FORECAST PERIOD 70
FIGURE 22 NORTH AMERICA WILL CONTINUE TO DOMINATE THE CELL EXPANSION MARKET
IN 2024 75
FIGURE 23 NORTH AMERICA: CELL EXPANSION MARKET SNAPSHOT 77
FIGURE 24 NUMBER OF NEW CANCER CASES IN LATIN AMERICA, 2018–2035 129
FIGURE 25 KEY DEVELOPMENTS IN THE CELL EXPANSION MARKET FROM 2016 TO 2019 135
FIGURE 26 SHARE OF COMPANIES IN THE CELL EXPANSION MARKET, 2018 136
FIGURE 27 MNM DIVE-VENDOR COMPARISON MATRIX: CELL EXPANSION MARKET 140
FIGURE 28 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2018) 141
FIGURE 29 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2018) 144
FIGURE 30 TERUMO BCT: COMPANY SNAPSHOT (2017) 146
FIGURE 31 MERCK KGAA: COMPANY SNAPSHOT (2018) 148
FIGURE 32 DANAHER CORPORATION: COMPANY SNAPSHOT (2018) 151

FIGURE 33 LONZA GROUP LTD: COMPANY SNAPSHOT (2018) 155
FIGURE 34 GE HEALTHCARE: COMPANY SNAPSHOT (2018) 159
FIGURE 35 CORNING, INC: COMPANY SNAPSHOT (2018) 161


★調査レポート[細胞増殖の世界市場予測(~2024年)] ( Cell Expansion Market by Product (Reagent, Media, Flow Cytometer, Centrifuge, Bioreactor), Cell Type (Human, Animal), Application (Regenerative Medicine & Stem Cell Research, Cancer & Cell-based Research), End User, and Region - Global Forecast to 2024 / BT-2850) 販売に関する免責事項
[細胞増殖の世界市場予測(~2024年)] ( Cell Expansion Market by Product (Reagent, Media, Flow Cytometer, Centrifuge, Bioreactor), Cell Type (Human, Animal), Application (Regenerative Medicine & Stem Cell Research, Cancer & Cell-based Research), End User, and Region - Global Forecast to 2024 / BT-2850) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆